… thyroid cancer (PTC), which is by far the most frequent form (>85%). Second is follicular thyroid
cancer (… of DTC are Hürthle cell cancer and poorly differentiated thyroid cancer 11 . PTC …

… While staging systems are useful in predicting survival for patients with differentiated thyroid
cancer, they do not adequately assess the risk of persistent or recurrent disease. Several …

… patients with GD have an increased risk of thyroid cancer (14). We reported previously that
differentiated thyroid cancer (DTC) occurring in patients … patients with hyperfunctioning thyroid …

… from 10 patients with primary well-differentiated thyroid cancer (WDTC) showed that the
metastases had progressed to a more poorly differentiated histopathology in 70% of the patients. …

… Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine
supplementation therapy. Support Care Cancer 2003;11 (9) 597- 603PubMed…

… Although other independent studies support our conclusion that differentiated thyroid cancer
concurrent to Graves’ disease is usually aggressive (13), some researchers have yielded …

… total thyroidectomy for patients with differentiated thyroid cancer is unknown. Several studies,
however, suggest that when treating papillary and follicular thyroid cancers larger than 1.5 …

… Patients with occult papillary thyroid cancer and minimally invasive follicular thyroid cancer
can be treated by thyroid … Virtually all other patients with differentiated thyroid cancer appear …

… retrospective review of papillary thyroid cancer patients treated with total thyroidectomy …
thyroid cancer center and followed according to the LATS management guidelines. Each patient …

… Long-term survival for patients presenting with stage IV thyroid cancer is about 43%,
compared with 86% in those with stage I disease (3–5). In patients with RAI-resistant disease, the …